Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-07

Clinical Trial Update: The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing PTH(1-84) and alendronate for reducing back pain in postmenopausal women with osteoporosis-related vertebral fractures; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PTH(1-84) (parathyroid hormone 1-84)
  • alendronate (alendronate)

Snippet

Sponsor: Nycomed | Conditions: Back Pain | Phase 4 | Status: TERMINATED | Results posted: 2011-10-07